BioSpace News Archive

Mitsubishi Tanabe Pharma Canada, Inc., a subsidiary of Mitsubishi Tanabe Pharma America, Inc., announced that RADICAVA®, an infusion treatment for amyotrophic lateral sclerosis, is now listed on the Nova Scotia Formulary.

A just published peer-reviewed study from Henry Ford Health System showed that the death rate of hospitalized patients who received hydroxychloroquine (HCQ) was cut in half, and there were no serious heart abnormalities.

LaunchPad Medical, Inc. announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study to examine the safety and efficacy of Tetranite®,

Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the closing of its previously announced public offering of 187,500,000 common shares (or common share equivalents) of the Company, together with warrants to purchase up to 187,500,000 common shares

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results after market close on Tuesday, August 4th, 2020.

Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that it has issued an aggregate of 5,594,593 shares of common stock at a price of $92.50 per share at the closing of the Company’s previously-announced public offering.

Avantor, Inc. announced the pricing of the previously announced private offering by its wholly-owned subsidiary, Avantor Funding, Inc., of $1.550 billion aggregate principal amount of 4.625% Senior Notes due 2028 and €400 million aggregate principal amount of 3.875% Senior Notes due 2028.

Ridgeback Biotherapeutics announces the start of enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801.

Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced the successful completion of the refinancing of its capital structure

EmbedTek, LLC, a technology (IoT) company specializing in the design and manufacture of embedded computer systems, software, sensors, and integrated displays, announced today that it has begun production and is accepting orders for PariRange™, a peer-to-peer social distancing and contact tracing device.